Candidate gene
| allele sharing with NOS2A and other markers of chromosome 17 (D17S949, D17S799) |
|
candidate for MS susceptibility |
Marker
| potential relevance of NOS2 as a prognostic factor for glioma malignancy and recurrence  |
|
NOS2 is a predictor of prognosis in early stage, resected PDAC patients  |
Therapy target
|
|
System | Type | Disorder | Pubmed |
cancer | digestive | pancreas |  |
targeting NOS2 may have potential therapeutic value in pancreatic ductal adenocarcinoma | cancer | angiogenesis | |  |
Therapeutic manipulation of iNOS levels may remove a critical cytoprotective mechanism of importance in tumour angiogenesis |
|